Cindy Whitehead

Cindy Whitehead is a highly regarded entrepreneur, a strong advocate for female entrepreneurship, a pharmaceutical leader and one of the few self-made woman billionaires in history. The New York Times called her pharmaceutical product the “drug of a generation” and Fortune called her a “tireless force of nature.” Associates of hers call her unapologetically pink.

Over a distinguished 22-year career in healthcare, she started and sold two businesses for more than $1.5 billion. Having co-founded and sold Slate Pharmaceuticals, which redefined long lasting testosterone treatment for men, she launched Sprout Pharmaceuticals immediately thereafter. As Co-Founder & CEO of Sprout, the company broke through with the first ever FDA-approved drug for low sexual desire in women — dubbed “female Viagra” by the media. In 2015, Cindy sold the company for $1b cash. Everyone that was a part of the original Slate was gifted shares in Sprout.

Cindy’s work has been featured in major publications including The New York Times, Fast Company, Financial Times, Vanity Fair, Bloomberg, CNBC, CBS, Fox, Yahoo and on the cover feature of Entrepreneur Magazine. Cindy has been an invited speaker at Fortune’s Most Powerful Women, the Fast Company Innovation Festival, Ad Week, Inc. Magazine, and many more. She is on a mission to speak to as many women as possible about what it takes to achieve breakthrough business success.

Cindy’s latest mission is to mentor, invest in, launch and build other women led or focused businesses. In 2016, she opened the doors to The Pink Ceiling — a cross between a VC firm, a ‘pinkubator’ and a consulting enterprise — where she is CEO. The company’s first investment is in Undercover Colors, a business that is developing nail polish intended to help wearers detect the presence of date-rape drugs.

In very rare moments she is hard at work trying not to work. But still wearing pink.